The nano enterprise: A survey of health and safety concerns, considerations, and proposed improvement strategies to reduce potential adverse effects
✍ Scribed by Reynold Sequeira; Ash Genaidy; Richard Shell; Waldemar Karwowski; Gary Weckman; Sam Salem
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 186 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1090-8471
No coin nor oath required. For personal study only.
✦ Synopsis
Nanotechnology is evolving to become a leading industry. However, there is a great deal of uncertainty surrounding the potential health effects of nanomaterials and its components. This study focuses on the hazards and risks that nanomaterials pose to physical and environmental health together with the risks posed during their manufacture and research. In particular, the authors seek to promote awareness and the need for the adoption of various strategies to minimize the risk of human exposure to nanotechnologies both within and outside the manufacturing enterprise. Information from scientific journals, project studies, environmental and worker-protection agency reports are used as the main source for this study. The six sigma's DMAIC framework, viz. "define, measure, analyze, improve, and control," is used as a guideline for synthesizing information from published literature. Preliminary evidence from experimental research studies indicate the ability of nanomaterials to penetrate and cause damage to human tissues and cells. The susceptibility of the personnel associated during production (those who are more likely to be at risk) has been analyzed to examine considerations and targets, as well as for developing strategies for a continued research framework. Nanotechnology may pose health and environmental hazards unless adequate preventive measures are developed and implemented. Because of the likely unfavorable health effects on individuals conducting experiments and handling nanomaterials, studies that identify the adverse effects of nanotechnology must be conducted at a pace level with the commercialization of nanotechnology.